Cargando…
Celecoxib Enhances the Efficacy of Low-Dose Antibiotic Treatment against Polymicrobial Sepsis in Mice and Clinical Isolates of ESKAPE Pathogens
Treatment of multidrug resistant bacterial infections has been a great challenge globally. Previous studies including our study have highlighted the use of celecoxib, a non-steroidal anti-inflammatory drug in combination with antibiotic has decreased the minimal inhibitory concentration to limit Sta...
Autores principales: | Annamanedi, Madhavi, Varma, Gajapati Y. N., Anuradha, K., Kalle, Arunasree M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420555/ https://www.ncbi.nlm.nih.gov/pubmed/28533769 http://dx.doi.org/10.3389/fmicb.2017.00805 |
Ejemplares similares
-
Celecoxib Sensitizes Staphylococcus aureus to Antibiotics in Macrophages by Modulating SIRT1
por: Annamanedi, Madhavi, et al.
Publicado: (2014) -
Conditions Under Which Glutathione Disrupts the Biofilms and Improves Antibiotic Efficacy of Both ESKAPE and Non-ESKAPE Species
por: Das, Theerthankar, et al.
Publicado: (2019) -
A Novel Alkaliphilic Streptomyces Inhibits ESKAPE Pathogens
por: Terra, Luciana, et al.
Publicado: (2018) -
Non-thermal Plasma Treatment of ESKAPE Pathogens: A Review
por: Scholtz, Vladimír, et al.
Publicado: (2021) -
Antimicrobial Activity of Gallium Compounds on ESKAPE Pathogens
por: Hijazi, Sarah, et al.
Publicado: (2018)